Psychiatry AtlasMedication guide · United States

Antidepressant that acts on serotonin

Vortioxetine (Trintellix, Brintellix)

Generic name
vortioxetine (as vortioxetine hydrobromide)
Brand names
Trintellix; Brintellix
Medication class
Antidepressant that acts on serotonin
Forms covered
Trintellix immediate-release oral tablets

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • Brintellix can be confused with Brilinta. Brintellix is the former US name of Trintellix (vortioxetine).

FDA Boxed Warning

Trintellix immediate-release oral tablets.

Antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults. Monitor everyone taking vortioxetine for worsening symptoms or emerging suicidal thoughts, especially when treatment starts or the dose changes. This medicine is not approved for children.

Vortioxetine (Trintellix) treats major depression in adults. Brintellix is its former US brand name.

Brintellix (historical brand).

What to expect: Fuller depression benefit may take several weeks or longer.

Warning signs
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Treatment of major depressive disorder in adults; not an approval for pediatric depression or every anxiety condition.Trintellix immediate-release oral tablets.

What should I expect?

Fuller depression benefit may take several weeks or longer. Track mood, interest and daily functioning rather than expecting immediate relief from a stressful moment.

Nausea can be noticeable early. Report persistent side effects, sexual difficulties or lack of improvement at follow-up; worsening mood or suicidal thoughts needs immediate attention.

How do I take it safely?

Take once daily with or without food. Trintellix is an immediate-release tablet, despite its relatively long persistence in the body.

Review all medicines: bupropion, fluoxetine and paroxetine can raise vortioxetine levels, while some seizure medicines and rifampin can lower them. Any dose adjustment belongs with the prescriber. Avoid alcohol.

Do not use with an MAO inhibitor. Wait at least 14 days after a psychiatric MAOI before vortioxetine and at least 21 days after vortioxetine before that MAOI. Do not start during linezolid or intravenous methylene-blue treatment.

Other medicines affecting serotonin can increase serotonin-syndrome risk; aspirin, anti-inflammatory pain medicines and blood thinners increase bleeding concerns. Discuss bipolar disorder, low sodium, narrow eye angles and prior allergy.

Discuss stopping first, particularly at higher doses; a reduction may help limit withdrawal symptoms. For a missed dose, take it when remembered unless the next is near, then skip. Never double.

Discuss pregnancy and breastfeeding, and do not abruptly change treatment because of pregnancy. Late exposure can affect the newborn or maternal bleeding; older adults are more vulnerable to low sodium. The US indication is adult depression.

What side effects should I know about?

  • Nausea, constipation or vomiting.
  • Sexual dysfunction can occur and should be discussed.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning: antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults in short-term studies. Monitor everyone for worsening depression, suicidal thinking or unusual behavior, especially when starting or changing a dose. These products are not approved for pediatric use. New suicidal thoughts require immediate clinical contact; immediate danger requires emergency help.
  • Get urgent medical care for fever with confusion or agitation, heavy sweating, diarrhea and stiff or twitching muscles. This combination may be serotonin syndrome, a potentially life-threatening reaction.
  • Contact the prescriber promptly for unusually high energy, very little need for sleep or risky behavior; these can be signs of mania.
  • Seek urgent care for severe confusion, significant bleeding or black stools, or a painful red eye with vision change. These may signal low sodium, bleeding or an acute eye-pressure problem.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Do not use after a vortioxetine allergy or with an MAO inhibitor. Allow at least 14 days after a psychiatric MAOI before vortioxetine and 21 days after vortioxetine before that MAOI. Do not start during linezolid or intravenous methylene-blue treatment.
  • Have other serotonin medicines, blood thinners, aspirin and anti-inflammatory pain medicines checked. Bupropion, fluoxetine, paroxetine and some enzyme-inducing medicines can require dose changes. Avoid alcohol; assess bipolar disorder, low sodium, bleeding risk and narrow eye angles.
  • Discuss dose reduction before stopping, particularly from higher doses. Pregnancy and breastfeeding need an individual discussion; late exposure can affect newborn adaptation and maternal bleeding. Older adults are more susceptible to low sodium.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • Brintellix and Trintellix refer to the same ingredient; Brilinta does not. Checking the generic name helps avoid this consequential name mix-up.
  • Different serotonin actions do not guarantee freedom from sexual side effects. These are worth discussing rather than silently accepting.
  • Vortioxetine stays in the body long enough that switching to an MAO inhibitor requires a particularly long waiting period.

How does it work?

Vortioxetine affects serotonin, a chemical messenger used by nerve cells. It slows serotonin’s return into the cell that released it and also acts directly at several serotonin receptors, the proteins that respond to the message. These actions are well described, but the contribution of each receptor effect to improvement in depression has not been established.

Explore medication science

How was this medicine developed?

Vortioxetine was approved in 2013 as Brintellix. The FDA approved the US name change to Trintellix in 2016 after confusion with Brilinta, a different medicine used to prevent blood clots.

How do I say the name?

Vortioxetine: vor-tye-OX-eh-teen. Capital letters show the stressed syllable.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Trintellix: current prescribing information
  2. Trintellix: FDA approval and supplement history
  3. Vortioxetine: patient medicine information
  4. FDA review: documented Brintellix to Trintellix name change
  5. Trintellix: FDA prescribing information
  6. Trintellix: Package Insert / Prescribing Information / MOA
  7. DailyMed - TRINTELLIX- vortioxetine tablet, film coated
  8. Viibryd: FDA prescribing information
  9. Vortioxetine: verified neutral parent, PubChem CID 9966051
  10. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  11. ISMP List of Confused Drug Names
  12. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  13. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
  14. Frequently Asked Questions about Labeling for Prescription Medicines | FDA

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top